Anna Swan’s extraordinary size and her record-setting pregnancies have fascinated people for more than a century, and much of the curiosity centers on how her body could accommodate the largest babies ever documented at the time. Standing close to 7 feet 11 inches tall, Swan had a frame that was proportionally scaled up from an average woman’s, including her skeletal pelvis and soft-tissue anatomy. That proportional enlargement is the key to understanding how she carried and delivered infants that weighed far more than any typical newborn. Her story sits at the intersection of pituitary gigantism, obstetric anatomy, and fetal overgrowth, and modern medicine now has much clearer answers about each of those pieces.
Who Anna Swan Was
Anna Haining Swan was born in 1846 in Mill Brook, Nova Scotia, to parents of ordinary stature. By her teens she had already surpassed six feet, and as an adult she was measured at roughly 7 feet 11 inches. She spent years performing with P.T. Barnum’s exhibitions in New York before marrying Captain Martin Van Buren Bates, a Kentucky native who himself stood about 7 feet 9 inches. The couple’s shared extreme height was not merely a stage novelty; it had profound medical implications, particularly when Anna became pregnant.
Her first pregnancy, in 1872, ended with a stillborn girl reported to have weighed around 18 pounds. Her second pregnancy, in 1879, produced a boy documented by the attending physician as weighing approximately 23 pounds 12 ounces and stretching about 30 inches long. That infant survived only 11 hours. Both deliveries were extraordinary medical events for the era, and the 1879 birth was entered into record books as the heaviest newborn on verified record at the time. Understanding why these outcomes occurred requires looking at what gigantism does to a woman’s body, how it affects fetal growth, and where the limits of safe delivery actually lie.
How Gigantism Reshapes the Skeleton and Soft Tissue
Pituitary gigantism results from the overproduction of growth hormone, usually by a benign tumor on the pituitary gland, before the growth plates of the long bones have closed. Because excess growth hormone acts on nearly every tissue in the body, the entire skeletal frame grows larger in a roughly proportional way. That includes the pelvis. A woman with gigantism does not simply have longer legs and arms; she has a wider, taller pelvic ring, larger pelvic inlet dimensions, and correspondingly larger soft-tissue structures throughout the birth canal.
This proportional scaling is the single most important anatomical fact for understanding childbirth in women with gigantism. The birth canal is not a fixed pipe; it is a ring of bone lined with muscle, connective tissue, and mucous membrane, all of which respond to the same hormonal environment that drives skeletal growth. In a woman standing nearly eight feet tall, the internal dimensions of the pelvis can be substantially larger than average, giving the fetal head and shoulders more room to pass through. The vaginal canal itself, being soft tissue, also scales with overall body size, stretches under the influence of pregnancy hormones, and is capable of accommodating a significantly larger infant than what a woman of average stature could deliver.
The Obstetrical Dilemma at Extreme Scale
In anthropology, there is a longstanding idea called the “obstetrical dilemma,” coined by Washburn in 1960. It describes the evolutionary tension between two competing pressures: selection for a wider pelvis so that large-brained human babies can pass through, and selection for a narrower pelvis that is more efficient for walking upright on two legs.1PubMed Central. The obstetrical dilemma hypothesis: there’s life in the old dog yet. This trade-off is reflected in the pronounced differences between male and female pelves. Women’s pelvic bones are wider and more rounded, an adaptation that appears to develop during puberty and is linked to estrogen levels.2PubMed Central. Developmental evidence for obstetric adaptation of the human female pelvis
For most women, the result of this evolutionary compromise is a tight fit between the baby’s head and the birth canal. Compared with other primates, humans have a remarkably snug match, which is why labor is long and difficult and why obstructed labor remains a leading cause of maternal death in parts of the world without access to surgical delivery.3PubMed Central. Biomechanical trade-offs in the pelvic floor constrain the evolution of the human birth canal In Anna Swan’s case, the usual tightness of this fit was relaxed by her enormous skeletal dimensions. Her pelvis was simply much larger than normal, meaning the ratio of baby size to canal size was less extreme than it would have been for an average-sized woman carrying an equivalently oversized baby. That said, even a proportionally generous pelvis has limits, and the sheer mass of her infants pushed those limits hard.
Why Her Babies Were So Enormous
A baby’s birth weight is shaped by multiple factors, and in Anna Swan’s case, nearly all of them pointed toward extreme size. Both parents carried genetic variants driving pituitary overgrowth, meaning the fetus inherited a predisposition toward rapid growth. On top of that, Anna’s own excess growth hormone during pregnancy likely contributed to an abnormal metabolic environment in the womb. Growth hormone influences insulin, glucose regulation, and nutrient transport across the placenta, and disruptions in these pathways are strongly linked to fetal macrosomia, the medical term for an abnormally large baby at birth.
Modern research has identified the major risk factors for macrosomia. Maternal diabetes, both pre-existing and gestational, is the strongest driver, roughly doubling the risk. Maternal obesity before pregnancy raises the risk about 1.6-fold, and excessive weight gain during pregnancy can increase it more than threefold.4PubMed Central. Extreme fetal macrosomia at 42 gestational weeks: a case report and literature review – Section: Discussion Other contributors include carrying a male infant and going past the due date. Anna’s situation was unusual because her excess growth hormone created a metabolic environment somewhat analogous to gestational diabetes: high circulating insulin-like growth factor, altered glucose handling, and enhanced nutrient delivery to the fetus. Combined with the genetic contribution of two giant parents, the result was a fetus that grew far beyond the macrosomic range, which itself begins at roughly 8 pounds 13 ounces in standard clinical definitions.
To put the numbers in perspective, a baby above about 10 pounds is considered macrosomic, and one above roughly 11 pounds enters the territory of extreme macrosomia. Anna Swan’s second baby weighed nearly 24 pounds, more than double the threshold for extreme macrosomia and roughly three to four times the weight of a typical full-term newborn. No modern maternal-fetal medicine team would allow a pregnancy to reach that point without intervention, and the fact that Anna attempted vaginal delivery reflects the limited options of 19th-century obstetrics rather than any indication that it was safe.
What Happens When Very Large Babies Are Delivered
Even in today’s births, macrosomic babies pose serious risks during delivery. A large multicenter study of first-time mothers found that macrosomia was independently linked to dramatically higher odds of shoulder dystocia, where the baby’s shoulders become stuck behind the mother’s pubic bone after the head has already emerged. The odds of this complication were more than 30 times higher for macrosomic babies compared to those of normal weight. Postpartum hemorrhage roughly doubled, blood transfusion rates went up about 2.5 times, and nerve injuries or broken collarbones in the infant were about nine times more common.5PubMed Central. Adverse perinatal outcomes associated with macrosomia in nulliparous women: A multicenter cohort study – Section: RESULTS Perineal tears and excessive bleeding were also significantly elevated with increasing birth weight in other studies.6PubMed Central. Foetal Macrosomia and Foetal-Maternal Outcomes at Birth – Section: Results
These risks follow a dose-response pattern: the heavier the baby, the worse the outcomes. And these numbers come from studies of babies in the 9-to-11-pound range. At nearly 24 pounds, Anna Swan’s delivery would have been in territory that modern research has essentially never documented, because no contemporary pregnancy would reach that point without cesarean intervention. The mismatch between the fetal body and the birth canal, even an enlarged one, is called cephalopelvic disproportion, and untreated, it leads to obstructed labor that can kill both mother and child.7PubMed. Assessing cephalopelvic disproportion: back to the basics Anna Swan survived both deliveries, which speaks to the exceptional dimensions of her pelvis, but neither baby survived long, and the births were described as agonizing and prolonged.
The Genetics Behind Pituitary Gigantism
When Anna Swan was alive, the cause of her extreme growth was a mystery. Today, researchers have mapped several genetic pathways that explain most cases of pituitary gigantism. One of the most striking discoveries came in 2014, when a team identified a previously unknown condition they named X-linked acrogigantism, or X-LAG. It is caused by a tiny duplication on chromosome Xq26.3 that leads to overexpression of a gene called GPR101. Every patient carrying this duplication developed gigantism starting in early childhood, typically before age five.8PubMed Central. Gigantism and Acromegaly due to Xq26 Microduplications and GPR101 Mutation
In families with a broader pattern of pituitary tumors, mutations in another gene called AIP account for about 20 percent of cases and are the most common single cause of pituitary gigantism, responsible for roughly 29 percent of familial gigantism cases. GPR101 duplications and AIP mutations represent different genetic routes to the same endpoint: a pituitary gland that pumps out far too much growth hormone during childhood, before the growth plates close, leading to extraordinary height.9PubMed. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA)
Anna Swan’s specific genetic mutation was never identified, since she died decades before genetic testing existed. But the clinical picture fits a growth-hormone-secreting pituitary adenoma that was active from early childhood. Both X-LAG and AIP-related gigantism can occur sporadically, meaning they can appear in a child born to parents of normal height, which matches Anna’s family history. Her husband Martin Bates likely had a similar condition, though again no genetic confirmation was ever possible. The combination of two parents with probable pituitary gigantism gave their children an extraordinary genetic push toward extreme fetal growth, on top of the abnormal hormonal environment of the womb.
How Pregnancy Is Managed in Women With Growth Hormone Disorders Today
Modern endocrinology has dramatically changed the outlook for women with growth-hormone-producing pituitary tumors. Treatment with medications like octreotide, a drug that suppresses growth hormone secretion, can control tumor growth, relieve symptoms, and even restore fertility in women whose tumors had previously made conception difficult.10PubMed. Inoperable Giant Growth Hormone-secreting Pituitary Adenoma: Radiological Aspects, Clinical Management and Pregnancy Outcome Medication is typically paused during pregnancy itself, but close monitoring of both tumor size and metabolic markers keeps complications in check.
The obstetric approach has changed just as much. When a fetus is suspected to be macrosomic based on ultrasound measurements, the delivery plan shifts toward cesarean section well before the baby reaches a size that would make vaginal delivery dangerous. There is no clinical scenario in which a modern obstetrician would allow a pregnancy to produce a 24-pound baby without intervening. Serial ultrasound, glucose monitoring, and growth-hormone assays would flag the problem months ahead of delivery. The combination of endocrine control and surgical delivery means that women with acromegaly or gigantism can now have successful pregnancies with far less risk than Anna Swan faced.
That said, there are still risks unique to this population. Growth hormone affects cardiac function and glucose metabolism, so women with acromegaly need cardiac screening and strict blood-sugar management throughout pregnancy. Tumor growth can resume or accelerate during pregnancy because of the hormonal changes involved, requiring repeat imaging. These pregnancies are high-risk by definition, managed by a team that includes both endocrinologists and maternal-fetal medicine specialists. The prognosis, though, is far better than anything available in the 1870s.
Why the Public Fascination Persists
Anna Swan’s story endures partly because it sits at the extreme end of several biological variables all at once: maternal height, fetal weight, and the biomechanical challenge of birth. Her case is an accidental natural experiment in what happens when the obstetrical dilemma’s usual constraints are loosened on the maternal side while fetal size escalates beyond anything the species normally produces. People searching for details about her anatomy are, at bottom, asking a question about limits: how large can a human birth canal actually be, and how large a baby can it accommodate?
The honest answer is that we do not know the absolute upper limit, because no one in modern medicine has any reason to find out. Cesarean sections remove the need to push those boundaries. What we do know is that the birth canal is not a rigid tube but a dynamic, hormonally responsive passage that varies enormously among women. Pelvic dimensions, soft-tissue elasticity, hormonal preparation during pregnancy, and the position of the baby all interact to determine what is deliverable and what is not. In a woman of Anna Swan’s size, all of these factors operated at an extreme scale, creating a birth canal substantially larger than average and capable of accommodating infants that would be impossible for a woman of ordinary stature to deliver vaginally.
There is no surviving medical measurement of Anna Swan’s specific pelvic dimensions or soft-tissue anatomy, and historical accounts were written by showmen and journalists as often as by physicians. What survives are the birth records, her documented height, and the reported weights and lengths of her babies. The rest has to be reconstructed from what modern science knows about proportional skeletal growth in gigantism. The picture those sources paint is of a woman whose reproductive anatomy was proportionally enlarged along with the rest of her frame, giving her a birth canal that was, in all likelihood, among the largest ever documented in a human, though still not large enough to make the delivery of a 24-pound baby anything other than extremely dangerous.
Fetal Survival and the Limits of Neonatal Viability in Extreme Macrosomia
A question that often gets overlooked in discussions of Anna Swan’s births is why neither baby survived. The answer lies not just in the trauma of delivery but in the physiology of extreme fetal overgrowth. Macrosomic infants, even in modern hospitals, face elevated risks of neonatal hypoglycemia, breathing difficulties, and metabolic instability immediately after birth. In the multicenter study discussed earlier, babies above about 10 pounds had more than double the odds of needing intensive care admission and more than double the odds of dangerously low blood sugar in the hours after delivery.11PubMed Central. Adverse perinatal outcomes associated with macrosomia in nulliparous women: A multicenter cohort study – Section: RESULTS
These complications stem from the same metabolic disruptions that caused the excessive growth in the first place. A fetus bathed in abnormally high levels of growth hormone and insulin produces its own excess insulin in response, and when the umbilical cord is cut and the maternal glucose supply stops, the baby’s blood sugar crashes. In 1879, there was no neonatal intensive care, no intravenous glucose, no respiratory support. Even if delivery had gone perfectly smoothly, a baby of that size born in that era faced metabolic challenges that 19th-century medicine simply could not address. The prolonged and traumatic labor only compounded the problem, likely causing physical injury and oxygen deprivation on top of the metabolic crisis.
Modern neonatal care has excellent protocols for managing macrosomic infants, including immediate blood-sugar monitoring and supplementation, respiratory support if needed, and close surveillance for birth injuries. Combined with elective cesarean delivery to avoid shoulder dystocia and prolonged labor, the outlook for very large babies today is dramatically better. None of this was available to Anna Swan, and the loss of both her children reflects the medical reality of her era as much as the biological extremity of her pregnancies.